PhaseBio Pharmaceuticals Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
PhaseBio Pharmaceuticals Inc has filed 371 SEC EDGAR filings since 25 Feb 2002

SEC filing history

Showing 76-100 of 364 matching filings.

Per page
25
Current page
4
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2022
Reporting date
24 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A filing

Filing date
15 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

PHASEBIO PHARMACEUTICALS INC

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90691

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC.

Filing date
01 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-262185

S-8

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-235735

424B5

Filing date
12 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .